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Amphiphilic Phthalocyanines in Polymeric Micelles: A 
Supramolecular Approach toward Efficient Third-Generation 
Photosensitizers  
Francesca Setaroa, Jos W. H. Wenninkb, Petri I. Mäkinenc, Lari Holappac, Panagiotis N. Trohopoulosd, Seppo Ylä-Herttualac, 
Cornelus F. van Nostrumb,*, Andres de la Escosuraa,e,*, Tomas Torresa,e,f,*
In this paper we describe a straightforward supramolecular strategy to encapsulate silicon phthalocyanine (SiPc) photosensitizers (PS) in polymeric micelles 
made of poly(ε-caprolactone)-b-methoxypoly(ethylene glycol) (PCL-PEG) block copolymers. While PCL-PEG micelles are promising nanocarriers based on 
their biocompatibility and biodegradability, the design of our new PS favors their encapsulation. In particular, they combine two axial benzoyl substituents, 
each of them carrying either three hydrophilic methoxy(triethylenoxy) chains (1), three hydrophobic dodecyloxy chains (3), or both kinds of chains (2). The 
SiPc derivatives 1 and 2 are therefore amphiphilic, with the SiPc unit contributing to the hydrophobic core, while lipophilicity increases along the series, 
making possible to correlate the loading efficacy in PCL-PEG micelles with the hydrophobic/hydrophilic balance of the PS structure. This has led to a new 
kind of third-generation nano-PS that efficiently photogenerates 1O2, while preliminary in vitro experiments demonstrate an excellent cellular uptake and a 
promising PDT activity. 
1. Introduction
The use of nanotechnology for medical purposes has grown 
exponentially over the past few decades. Research efforts in 
nanomedicine aim at developing nanostructured systems for 
therapy, diagnosis and therapy monitoring applications.1 In the 
field of photodynamic therapy (PDT), for example, third-
generation photosensitizers (PS) are composed of a second-
generation PS conjugated to or encapsulated in 
biodegradable/biocompatible nanoparticles, which broadens 
the PS clinical potential.2-4 Third-generation PS circumvent 
some of the deficiencies relative to second-generation PS, 
improving their pharmacokinetics, pharmacodynamics and 
biodistribution in vivo. In this respect, various nanoparticle 
types have been used as PS carriers, including the very 
promising polymeric micelles.5-7 Advances in fiber-optic based 
laser technologies also make feasible a highly selective local PS 
activation, even in deep and scarcely accessible tissues. 
Phthalocyanines (Pc)8−12 constitute one of the most 
promising families of second-generation PS. An important 
advantage of Pc, in comparison to other porphyrinoid PS, is their 
intense absorption within the therapeutic window.13−18 The 
absorption Q-band of Pc is almost two orders of magnitude 
more intense than the highest Q-band of haematoporphyrin, 
while they show hardly any absorption in the range of 400–600 
nm. Furthermore, Pc present high quantum yields and long 
lifetimes of their triplet excited state, which assist in the 
generation of singlet oxygen (1O2). A shortcoming of Pc in this 
field is, however, the strong tendency of their aromatic ring to 
aggregate, especially in water and aqueous buffered solutions, 
leading to a decrease or total loss of their photosensitizing 
capability.19 Consequently, one of the main challenges for 
chemists working on this topic is to synthesize Pc with a low 
aggregation tendency17 or, likewise, to embed them in 
nanosized architectures able to disrupt the aggregates.20-22 
Besides, Pc are hydrophobic compounds, which decreases their 
solubility in aqueous media. This problem can be solved by pure 
chemical means, i.e., through the inclusion of hydrophilic 
groups,19 or by encapsulation into water-dispersible 
nanocarriers.2-4 Polyester-based nanocarriers are the most 
suitable ones for that purpose considering their 
biocompatibility and biodegradability. Among them, micelle 
forming block copolymers of polyethylene glycol and polylactic 
acid (PLA-PEG)23 or poly(ɛ-caprolactone) (PCL-PEG)24 are the 
most frequently investigated.      
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Figure 1. Schematic representation of the proposed strategy toward third-generation PS based on the encapsulation of amphiphilic 
SiPc derivatives (compounds 1 and 2, while 3 serves as a reference lipophilic derivative) in PCL-PEG polymeric micelles. 
For instance, PCL-PEG micelles have been successfully 
implemented for the efficient solubilization and enzymatically 
controlled release of temoporphin (mTHPC),25,26 a PS clinically 
used in PDT of head and neck cancers. Importantly, the 
introduction of aromatic groups in the polymer chain can 
strongly aid in the encapsulation of the PS through aromatic -
 stacking interactions,27 for example by substitution of the PCL
chain ends by aromatic groups (benzyl or naphthyl).25
On these bases, herein we describe the incorporation of 
novel amphiphilic silicon Pc (SiPc) compounds into polymeric 
micelles formed by block copolymers of benzyl or naphthyl 
substituted poly(ε-caprolactone)-b-methoxypoly(ethylene 
glycol) (ben-PCL-PEG and nap-PCL-PEG, respectively) and their 
use as efficient third-generation PS (Figure 1). The 
supramolecular character of this encapsulation strategy renders 
it simple from the synthetic point of view, and gentle regarding 
the conditions required for micelle loading. In the PCL-PEG 
micelles, the hydrophobic polyester segments are located in the 
micellar core, allowing the PS to locate at such core or across 
the core-shell interface, depending on the PS nature. We will 
show in this paper that tuning the hydrophilic/hydrophobic 
balance of the SiPc axial substituents, or the (aromatic) chain 
end and polyester block lengths in the micellar structure, allows 
optimizing both the loading efficiency and PS aggregation inside 
the micelles, thus enhancing the observed photodynamic 
effect. To prove the utility of such an approach, we also show 
proof of concept of the excellent in vitro PDT efficacy and 
cellular uptake of these promising third-generation PS.  
2. Experimental section
The list of instruments, materials, synthetic methods for the 
preparation of SiPc 1-3 and micellar block copolymers, 
characterization of the compounds, and singlet oxygen 
generation capacity of the three PS, are listed in the ESI. 
2.1. Protocol for micelle formation 
Pure micelles and those loaded with SiPc compounds 1-3 were 
formed by the film hydration method.25 In short, 10 mg of ben-
PCL-mPEG or nap-PCL-mPEG block copolymers were dissolved 
in 1 mL of dichloromethane. 5 mg of SiPc compound 1, 2 or 3 
were dissolved in 1 ml of THF and different amounts 
corresponding to the desired polymer/PS ratios were mixed 
with the dichloromethane block copolymer solution. By 
evaporation of dichloromethane and THF a thin solid film was 
formed. The formed film contained both block copolymers and 
homogenously distributed PS. The block copolymer (plus PS) 
film was subsequently dissolved in 1 mL PBS solution by gentle 
shaking and after 1 hour filtered through a 0.2 µm syringe filter, 
to remove non-encapsulated and thus precipitated SiPc. This 
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procedure results in empty micelles or PS loaded micellar 
solutions of 10 mg/mL ben-PCLn-mPEG45 or nap-PCLn-mPEG45. 
2.2. Procedure to determine loading efficiency and loading 
capacity  
The concentration of SiPc compounds 1-3 in micellar 
dispersions was determined by UV-Vis spectroscopy. The 
dispersions were diluted in DMF to dissolve the micelles. A 
spectrum between 300 nm and 800 nm was recorded by a 
Shimadzu UV-2450 spectrophotometer (Shimadzu, Japan). The 
absorbance at 686 nm was analyzed against a calibration curve 
of SiPc 1-3 in DMF, which was linear between 0 and 6 µg/ml. 
The loading efficiency (LE) and loading capacity (LC) were 
calculated by Equations 1 and 2, respectively. 
𝐿𝐸 (%) =  
𝑆𝑖𝑃𝑐 𝑐𝑜𝑚𝑝𝑜𝑢𝑛𝑑𝑠 𝟏−𝟑 𝑙𝑜𝑎𝑑𝑒𝑑 (𝑚𝑔)
𝑆𝑖𝑃𝑐 𝑐𝑜𝑚𝑝𝑜𝑢𝑛𝑑𝑠 𝟏−𝟑 𝑓𝑒𝑑 (𝑚𝑔)
𝑥100%          (1) 
𝐿𝐶 (%) =  
𝑆𝑖𝑃𝑐 𝑐𝑜𝑚𝑝𝑜𝑢𝑛𝑑𝑠 𝟏−𝟑 𝑙𝑜𝑎𝑑𝑒𝑑 (𝑚𝑔)
𝑝𝑜𝑙𝑦𝑚𝑒𝑟  𝑢𝑠𝑒𝑑 (𝑚𝑔)+𝑆𝑖𝑃𝑐 𝑐𝑜𝑚𝑝𝑜𝑢𝑛𝑑𝑠 𝟏−𝟑 𝑙𝑜𝑎𝑑𝑒𝑑 (𝑚𝑔)
𝑥100% (2) 
2.3. In vitro biological studies 
For photodynamic cell-killing experiments, mouse macrophage 
RAW264.7 (ATCC; TIB-71) cell line was cultured in Dulbecco's 
Modified Eagle's Medium (DMEM) supplemented with 10 % 
FBS, 1% penicillin-streptomycin. The cell killing efficacy of the 
different micellar compositions was analyzed using MTS-assay 
(Promega). Cells were first split into a 96-well plate, and one day 
later the PS-micellar hybrids were applied to the cells and 
subsequently allowed to incubate with the cells for 2h. After 
this, cells were illuminated with a custom-made LED device 
emitting light at 670 nm wavelength for 10 minutes, with LED 
light intensity of 3.04 mW/cm2. 24 hours later MTS-reagent was 
applied to the plate, and measured one hour later by 
spectrophotometry (Multiskan Ascent, MTX Labsystems). Cells 
without PS-micellar compositions and without light activation 
were always used as a control. 
For fluorescence microscopy, cells were split into chamber 
slides. One day later, the PS-micelle hybrids were applied to the 
cells. After 2h of incubation, cells were rinsed with PBS and fixed 
with 1% paraformaldehyde. Images were taken with Nikon 
Eclipse Ni-e (Nikon Corporation, Japan). 
3. Results and discussion
3.1. Synthesis and characterization of amphiphilic SiPc-based PS 
As PS, we have chosen to use SiPc derivatives because they have 
a proven clinical potential for PDT, and their properties can be 
tuned through the introduction of different substituents at axial 
positions of the Pc macrocycle.28−33 The target SiPc compounds 
(1-3, see Figure 1) bear two axial benzoyl substituents, each of 
them with either three methoxy(triethylenoxy) chains (1), three 
dodecyloxy chains (3), or both kinds of chains (2). Consequently, 
the SiPc derivatives 1 and 2 are amphiphilic, with the SiPc unit 
contributing to the hydrophobic core, while lipophilicity 
increases along the series, making possible to correlate the 
loading efficacy in PCL-PEG micelles with the 
hydrophobic/hydrophilic balance of the PS structure. The 
synthesis of 1-3 (for details: see Supplementary Information) 
took place by nucleophilic displacement of the chlorine atoms 
from the commercially available silicon phthalocyanine 
dichloride (SiPcCl2) with an excess of the corresponding benzoic 
acid derivatives (up to 10 eq., in a 1:1 mixture for the case of 3) 
under reflux of 2-methoxyethyl ether for 6 h (Scheme 1). The 
compounds were then purified by column chromatography, 
using mixtures of DCM and methanol as eluent, and fully 
characterized by NMR (Figure S1), UV-Vis and FT-IR 
spectroscopies, and MALDI-TOF spectrometry (see SI). The 
solubility of each of these PS is determined by the axial 
substituents. SiPc 1 is for example soluble in polar solvents, 
including water, while in non-polar solvents it forms a gummy 
solid that is impossible to filter. SiPc 2, in turn, is soluble in a 
range of polar and non-polar solvents such as methanol, 
acetone, THF, DCM and hexane. Finally, the lipophilic SiPc 3 is 
only soluble in non-polar organic solvents such as DCM and 
hexane, and serves in our study as a reference compound.  
Scheme 1. Synthesis of the SiPc derivatives 1-3. 
The UV/Vis spectra of compounds 1, 2 and 3 were initially 
recorded in chloroform (Figure 2a), where, despite its non-
coordinating nature, they are clearly non-aggregated, as 
revealed by the sharp Q-band present at 686 nm. As expected, 
increasing the number of methoxy(triethylenoxy) chains 
decreases the PS absorption intensity, so the extinction 
coefficient of the amphiphilic species 2 has an intermediate 
value (ε = 2.6 x 105 M-1cm-1) with respect to the symmetric 
analogues 3 (ε = 3.1 x 105 M-1cm-1) and 1 (ε = 1 x 105 M-1cm-1). 
Because compound 1 is hydrophilic, its absorption spectrum 
could also be recorded in polar solvents (Figure 2b). In methanol 
(Figure 2b, dashed line), the Q-band absorption maximum 
suffers a slight hypsochromic shift (i.e. centered at 683 nm) 
compared to that obtained in chloroform (i.e. centered at 686 
nm, solid line). The extinction coefficient value of 1, in turn, is 
twice higher in methanol (ε = 2 x 105 M-1cm-1), probably because 
the compound is better dissolved in this solvent. Importantly, 
PS 1 is also soluble in aqueous solution, if it is injected from a 
concentrated solution in MeOH or DMSO (1% of the total 
volume). As shown in Figure 2b (dotted line), under these 
conditions the spectrum changes completely, compared to that 
in chloroform, with the Q-band presenting two major peaks: 
one centered at 698 nm, corresponding to the monomeric 
species, and the main and bathochromically shifted band with 
maximum absorption at 738 nm, which is probably due to 
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formation of J-aggregates. To explain this result, as for other 
SiPc derivatives previously reported,34−37 we hypothesize that in 
water 1 assumes a conformation where the hydrophilic part of 
the molecule is exposed to the polar environment, thus 
promoting π-π interactions of the aromatic macrocycle and 
consequently J-type stacking (further discussed below).  
Figure 2. (a) UV-Vis spectra of compounds 1 (blue), 2 (green) and 
3 (red) in chloroform (M = 2 x 10-6 mol/L). (b) UV/Vis spectra of 
the SiPc 1 in chloroform (solid line, M = 2 x 10-6 mol/L), methanol
(dashed line, M = 2 x 10-6 mol/L) and water (with 1% methanol) 
(dotted line, M = 1 x 10-5 mol/L).
In order to assess the photosensitizing ability of our SiPc 
derivatives in solution, the 1O2 quantum yields () of 
compounds 1-3 were determined through the relative 
method,38 based on measuring the rate of photodegradation of 
a chemical scavenger (1,3-diphenylisobenzofuran -- DPBF) that 
is directly proportional to the formation of 1O2 (Figure 3). The 
measurements were conducted in DMSO, with the exception of 
SiPc 3, which for solubility reasons had to be measured in THF. 
The solvent choice aimed at ensuring that the Pc system 
remained in a non-aggregated state, a requirement for 1O2 
generation at the maximum PS capacity. Figure S2 shows as a 
representative example the decay of the scavenger absorption 
induced by PS 1 during irradiation, while data for compounds 2 
and 3 were almost identical. Decrease in Q-band intensity or 
appearance of new bands were not observed in any case, 
ensuring the PS integrity over the whole experiment.  
Figure 3. Plot of the decrease in DPBF absorption with time, 
photoinduced by non-substituted ZnPc (as reference compound, 
black data), the SiPc 1 (red data), the SiPc 2 (green data), and 
the benchmark PS Pc 4 (blue data), which correlates with singlet 
oxygen produced by each of these PS.    
Under these circumstances, plotting the dependence of 
ln(A0/At) against irradiation time (t) (with A0 and At being the 
respective scavenger absorbance values at the monitoring 
wavelength before and after the irradiation time t) affords a 
straight line whose slope reflects the PS efficacy to generate 
1O2, and from which   can be calculated (see SI). Taking non-
substituted ZnPc as the reference compound ((DMSO) = 
0.67),39,40 the scavenger photodegradation profiles induced by 
the SiPcs 1 and 2 (Figure 3) correspond to  values of 0.27 and 
28, respectively. The  for SiPc 3 was calculated to be 0.27, but 
it was measured in a different solvent (THF) and so the 
corresponding plot is not comparable in Figure 3.  The fact that 
 is almost identical for the three compounds correlates well 
with the similar chemical features of their axial substituents, 
only differing by their side chains, which tune the solubility and 
aggregation properties but do not affect the electronic 
structure of the SiPc core. For comparison, we also measured 
the 1O2 quantum yield of the SiPc derivative Pc 4 in DMSO 
(Figure 3, blue data), i.e., the benchmark PS among the family 
of Pcs.41 The resulting value ((Pc 4) = 0.20) is lower than those 
obtained for 1-3, revealing that the photodynamic behavior of 
the new SiPcs is at the same level or even superior to the best 
PS systems in the field of PDT. 
3.2. Loading of amphiphilic SiPc-based PS into PCL-PEG micelles 
In order to combine the previously synthesized PS with 
polymeric micelles, a library of Ben-PCL-PEG and Nap-PCL-PEG 
block copolymers with varying PCL chain lengths (on average 7-
19 units) and a fixed PEG block (MW of 2000 Da) were prepared. 
These syntheses were carried out through ring opening 
polymerization of -caprolactone by benzyl or naphtyl alcohol, 
respectively, followed by activation of the hydroxyl end group 
and reaction with amine-terminated -methoxypolyethylene 
glycol (details of synthesis and characterization: see SI). The 
molecular weights of the synthesized mPEG45-NH2, 
intermediate PCL polymers and the final Ben-PCL-PEG and Nap-
PCL-PEG block copolymers were characterized by GPC, and the 
results are given in Table S1 and Figure S3.  
Figure 4. (a) Loading efficiency (top) and capacity (bottom) of SiPc 1 in PBS-dispersions of Ben-PCL11-PEG polymeric micelles. (b) UV-
Vis spectra of 6% SiPc 1 in Ben-PCL11-PEG micelles (composition 6, red line) and in DMF (blue line). (c) UV-Vis spectra of 1% SiPc 2 in 
Ben-PCL11-PEG micelles (composition 16, red line) and in DMF (blue line). 
The GPC chromatograms of Figure S3A show for example that the 
Ben-PCL19-OH and mPEG45-NH2 peaks shift to the new Ben-PCL19-
mPEG45 peak and remain narrow. There are no residual peaks visible 
at the retention times of the mPEG45-NH2 and Ben-PCL19-OH. These 
results are indicative for a successful synthesis and coupling reaction. 
PS 1-3 loaded micelles of both Ben- and Nap-PCL-PEG were 
then prepared by the film hydration method.25 First, a solution 
of the amphiphilic polymer in DCM was mixed with various 
amounts of a solution of the PS (5 mg/mL) in THF. The mixture 
was gently shacked for a minute and the solvents were rotary 
evaporated, giving rise to a thin film of block copolymer with 
homogenously distributed PS. Heating the thin film up to 60 ˚C 
during subsequent hydration by phosphate buffered saline 
(PBS, pH 7.4) was necessary to optimize the encapsulation 
process and to prevent aggregation of the PS. The resulting 
dispersion was filtered through a 200 nm syringe filter to 
sterilize the solution and remove dust and non-encapsulated PS. 
Details of this procedure are provided in the Experimental 
Section (see above). 
A comprehensive series of hybrid nanosystems were thus 
prepared, differing in the number of caprolactone repeat units 
present in the polymer, the aromatic end-group of the 
poly(caprolactone) chain, the nature of the SiPc compound, and 
the loading of SiPc in the polymeric micelles (see Table S2). The 
amount of encapsulated PS in all prepared compositions was 
measured by diluting and dissolving the micelles in DMF and 
measuring PS concentration by UV/Vis spectrophotometry, 
allowing to determine the loading capacity (LC, wt% of SiPc in 
micelles) and loading efficiency (LE, % encapsulated with 
respect to feed %) in each particular case. The results are shown 
in Figures S4 and S5. TEM and DLS characterization of the 
micelles was unfortunately impossible, due to their small size 
and absorption of the DLS wavelength by the PS, respectively. 
From the data of Figures S4 and S5, it is anyway clear that the 
most efficient encapsulations were obtained when using Ben-
PCL-PEG micelles (Compositions 1-20 and 36-44). Among them, 
the optimum PCL length corresponds to eleven caprolactone 
monomers, probably because crystallinity of the PCL block 
increases with chain length, thus hampering encapsulation.26 
Concerning the PS, encapsulation of the lipophilic SiPc 3 is highly 
inefficient (Compositions 1-5 and 36-38), while the most 
hydrophilic SiPc 1 gives rise to the best LC and LE values 
(Compositions 6-15 and 39-41). Loading efficiency was almost 
quantitative (82 - 99 wt%) at SiPc 1 to polymer feed ratios of <10 
wt%, leading to a proportional increase in loading capacity with 
increasing feed ratio (Figure 4a, top). However, loading 
efficiency decreased when the feed ratio increased to 10 and 
20%. Concerning loading capacity, a maximum value of 6% 
could be obtained (Figure 4a, bottom).  
Figure 5. Proposed hypothetical structure of the supramolecular dimers formed by the amphiphilic SiPc derivatives (a) 1 and (b) 2. 
The dimer of 1 has an hydrophilic shell of methoxy(triethylenoxy) chains, in contrast to the amphiphilic character of the monomer, 
explaining why this compound aggregates in water (see Figure 2b) but not within the PCL-PEG micelles (Figure 4b). On the other 
hand, the dimer of 2 is amphiphilic, thus favoring its formation within micelles, probably at the core-shell interface. 
UV-Vis spectroscopy gave information about the 
aggregation behavior of the SiPc derivatives 1 and 2 within the 
micellar environment (Figure 4b, c) compared to that in other 
solvents where they are soluble (see also Figure 2). The spectra 
of compositions containing SiPc 1 in different micellar systems 
present the characteristic features of non-aggregated SiPc, with 
a sharp Q-band centered at 686 nm. This effect is illustrated in 
Figure 4b, showing the UV-Vis spectrum obtained for 6% SiPc 1 
in Ben-PCL11-PEG micelles (red line), compared to that of SiPc 1 
in DMF (blue line). This is highly advantageous for singlet oxygen 
production upon illumination and clearly different from the 
spectrum of SiPc 1 in water as was shown in Figure 2b. In 
particular, the spectrum in water shows a red-shift of the Q-
band that is indicative of J-aggregate formation,42 which 
supports that in presence of micellar Ben-PCL11-PEG this PS is 
truly encapsulated in the micelles rather than being dispersed 
in the aqueous medium. In water, the finding of J-aggregation 
suggests that the SiPc exists as a hydrophilic supramolecular 
structure (Figure 5a), which is not favored upon encapsulation 
in the PCL-PEG micelles, where the amphiphilic monomer is 
probably better accommodated at the micellar core-shell 
interface. On the contrary, micelles of Ben-PCL11-PEG that 
contain 1% of compound 2 did show a strong PS aggregation, 
with a clear red shift and splitting of the SiPc Q-band (illustrated 
in Figure 4c, red line), as compared to the spectrum of the same 
PS in DMF (Fig. 4c, blue line) or in chloroform solution (Figure 
2a). Again, these spectral changes are characteristic of Pc J-
aggregates. Based on that, figure 5b presents a hypothesized 
scheme of the aggregation mode of this amphiphilic SiPc, likely 
promoted at the micelles core-shell interface. 
3.3. In vitro studies 
Once the best couple of PS and micellar carrier was chosen (SiPc 
1 / Ben-PCL11-PEG), we proceeded to study the PDT potential of 
the resulting third-generation PS at the highest feed ratio (20%, 
with 6% LC). The ability of this nano-PS to induce cell killing was 
studied in a mouse macrophage cell line RAW 264.7, as 
macrophages play a prominent role in atherosclerosis,43 and in 
malignancy in the stromal and leukocyte compartment. Distinct 
macrophage subsets have also been described in cancer,44 for 
which RAW 264.7 cells constitute a good model system for the 
in vitro study of both atherosclerosis and cancer PDT. For the 
experiment, a custom-made LED device (λ = 670nm) for 
illuminating individual cells on a 96-well plate was used. The 
illumination time was 10 minutes, with a LED light intensity of 
3.04 mW/cm2. Cells without nano-PS and/or without light 
activation were used as a control. Besides, a wide range of 
dilution series was tested, and cells were incubated 24 hours 
after LED-illumination before measuring the photocytotoxicity. 
The IC50-value determined from these experiments was 
approx. 35 ng/µL of polymeric micelles (corresponding to 1.2 
M of SiPc 1), while no dark toxicity was observed up to 
concentration of 500 ng/µL (Figure 6a).  
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Figure 6. (a) Cell killing induced by 6% SiPc 1 / Ben-PCL11-PEG 
micelles (composition 6) in RAW-cells. The viability of the cells 
was measured by MTS-assay (Promega) after 10 min LED 
illumination (3.04 mW/cm2, blue bars) or without illumination 
(dark toxicity, orange bars). (b-d) Fluorescent microscopy 
images from RAW cells after treatment with 6% SiPc 1 / Ben-
PCL11-PEG micelles at (c) 10 ng/mL and (d) 100 ng/mL. Cells 
without nano-PS serve as controls (CTRL, panel b). Scale bar 200 
µm. 
Finally, cellular uptake studies were performed for the SiPc 
1 / ben-PCL11-PEG hybrid nano-PS. The ability of SiPc 1 to enter 
the macrophage cells was analyzed by fluorescence microscopy. 
Figure 6b-d shows fluorescent microscopy images from RAW 
cells after 2 h incubation with 6% SiPc 1 / Ben-PCL11-PEG 
micelles. Cells without nano-PS serve as controls (CTRL, Figure 
6b). As seen from Figure 6c, the red fluorescence indicates that 
at a concentration of 10 ng/µl a majority of cells contain the 
fluorescent nano-PS. Furthermore, 100 ng/µl concentration 
leads to strong fluorescence seen in all cells (Figure 6d). This 
result, together with the above phototoxicity data, 
demonstrate the promising PDT potential of the studied nano-
PS, as compared to other standards in the field. 
4. Conclusions
In summary, herein we have developed a series of SiPc silyl ester 
derivatives with increasing hydrophilicity of their axial 
substituents, which in the case of compounds 1 and 2 resulted 
in amphiphilic PS that can efficiently be incorporated into 
polymeric micelles by supramolecular means. The best loading 
efficiency and loading capacity values have been observed for 
the SiPc 1, with the additional advantage that it does not 
aggregate within the micellar environment, thus preserving its 
photosensitizing properties intact. Consequently, the resulting 
nanosystem is an efficient third-generation PS, as 
demonstrated by in vitro PDT and cellular uptake experiments 
using a model macrophage cell line. In vivo experiments will be 
devoted in the future to clarify its clinical potential. 
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